Home > James R Klinger, CHEST 2018 – Management of pulmonary arterial hypertension
Pulmonary Hypertension

James R Klinger, CHEST 2018 – Management of pulmonary arterial hypertension

Published Online: October 12th 2018

James R Klinger (Rhode Island Hospital, and Warren Alpert Medical School, Brown University, Providence, RI, US) chats to us on the topic of his session entitled: Current Quandaries in Pulmonary Arterial Hypertension (PAH) Management.


1. What are the major challenges in the management of pulmonary arterial hypertension (PAH)? (0:10)
2. What have been the most important recent developments in PAH therapy? (0:44)
3. What are the pros and cons of front line combination therapy versus sequential therapy? (1:22)
4. What is the role of oral anticoagulation therapy in the management of PAH? (2:17)
5. What are the major gaps in our knowledge of PAH management that require addressing? (2:53)

Speaker disclosure: James R Klinger’s institution receives grant support from Actelion, Bayer, Eiger BioPharmaceuticals, Lung International and United Therapeutics.

Filmed at the CHEST Annual Meeting, San Antonio, TX, US, October 2018.

Share this Video
Related Videos In Pulmonary Hypertension
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots padlock person play_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar